RELATED CONTENT
July 26, 2022 — Aidoc, a leading provider of AI healthcare solutions, today announced a partnership with UofL Health, a ...
July 26, 2022 
March 31, 2022 — Aidoc, a leading provider of healthcare AI solutions, announced that it received FDA 510(k) clearance ...
March 31, 2022 
May 8, 2020 — Aidoc announced that the U.S. Food and Drug Administration (FDA) has allowed the use of their cleared AI ...
May 08, 2020 
February 28, 2020 — LucidHealth, a physician-owned and led radiology company, announced today that it is using an AI ...
February 28, 2020 
Global Diagnostics Australia (GDA), a subsidiary of the Integral Diagnostics Group (IDX), has adopted artificial intelligence (AI) applications into its radiology workflow, and is one of the first diagnostic imaging companies in Australia to do so. GDA has partnered with AI company Aidoc to incorporate their algorithms into GDA's care management pathway. These AI applications will expedite patient diagnosis and treatment for several head, neck and chest conditions.
September 04, 2019 
Montefiore Nyack Hospital, an acute care hospital in Rockland County, N.Y., announced it is utilizing artificial intelligence (AI) software to assist in identifying urgent life-threatening conditions on patient computed tomography (CT) scans. The commercial solution from medical AI company Aidoc automatically prioritizes critical medical conditions, ensuring patients are diagnosed and treated faster. Montefiore Nyack is the first regional hospital in the New York metropolitan area to use Aidoc, joining more than 160 medical centers worldwide.
August 05, 2019 
Radiology artificial intelligence (AI) provider Aidoc announced the U.S. Food and Drug Administration (FDA) has cleared the world’s first AI solution for triage of cervical spine fractures. The latest 510(k) clearance is Aidoc’s third, coming just weeks after the FDA cleared Aidoc’s pulmonary embolism solution. By prioritizing suspected C-spine fracture cases in a radiologist’s worklist, Aidoc’s AI-powered triage automatically prioritizes critical cases, ensuring they are diagnosed by a radiologist in the most timely manner.
June 11, 2019 
Artificial intelligence (AI) solutions provider Aidoc has been granted U.S. Food and Drug Administration (FDA) clearance for an additional product in its expanding suite of AI-based workflow orchestration solutions. The clearance is for Aidoc's Pulmonary Embolism (PE) solution that works with radiologists to flag and triage PE cases in chest computed tomography (CT) scans. The approval comes just weeks after Aidoc closed a $27 million funding round, bringing its total funding to $40 million.
May 15, 2019 
Radiology artificial intelligence (AI) solutions provider Aidoc announced a $27 million investment, bringing its total funding to $40 million. The Series B round, led by Square Peg Capital, will be used to grow Aidoc's technology and go-to-market team.
May 02, 2019 
Artificial intelligence (AI) radiology solution provider Aidoc announced the commercial release of its CE-marked product for the identification and triage of pulmonary embolism (PE) in computed tomography (CT) pulmonary angiograms. By flagging obstructions in blood-flow to the lungs, Aidoc prioritizes radiologists’ work queues and helps them detect critical conditions faster, leading to quicker treatment and saving lives.
March 04, 2019